🕵️ Kailera Therapeutics, Inc. ($KLRA)
SEC insider & ownership activity, last 12 months · CIK 2096997 · every row links its SEC filing
Over the last 12 months insiders bought $326.8M with no open-market selling against it. BAIN Capital Investors LLC bought $134.4M in discretionary trades (Apr). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
5 buyers, $326.8M (5 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| BAIN Capital Investors LLC | 1 | $134.4M | 0 | – | Apr 20, 2026 |
| Andrew T. Kaplan | 1 | $134.4M | 0 | – | Apr 20, 2026 |
| BAIN Capital Life Sciences Investors, LLC | 1 | $25.0M | 0 | – | Apr 20, 2026 |
| Koppel Adam | 1 | $25.0M | 0 | – | Apr 20, 2026 |
| RTW Investments, LP | 1 | $8.0M | 0 | – | Apr 20, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| BCPE Perseus Investor, LP | 20.3% | 13D | Apr 16, 2026 | filing ↗ | |
| BCLS Fund IV Investments, L.P. | 17.4% | 13D | Apr 16, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | May 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 26, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Apr 20, 2026 | filing ↗ |
| Other events (8.01) | Apr 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 20, 2026 | filing ↗ |